Raising access to cancer diagnostics through targeted gene expression & AI powered analysis.
The cancer care gap starts at diagnosis
Cancer is the second leading cause of death globally and often surpasses the burden of infectious diseases in low- and middle-income countries. Approximately 70% of cancer deaths occur in these countries. In many cases the right medicine is available, but the right diagnosis is missing.
A low-cost, accurate cancer diagnostic can change this.
Connect & Collaborate
We welcome collaboration with the public, private and non-profit sectors to extend the use of our technology and to develop new solutions for low-cost cancer diagnostics.